Protection from type 1 diabetes by vitamin D receptor haplotypes

Annals of the New York Academy of Sciences

Volumn 1079, Issue , 2006, Pages 327-334

  Ramos Lopez, Elizabeth ^a   Jansen, Thomas ^a   Ivaskevicius, Vytautas ^b   Kahles, Heinrich ^a   Klepzig, Christian ^a   Oldenburg, Johannes ^b   Badenhoop, Klaus ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b Institute of Transfusion Medicine and Immunohaematology   (Germany)

Author keywords

Type 1 diabetes; Vitamin D; Vitamin D receptor

Indexed keywords

CALCIFEDIOL; CALCITRIOL; VITAMIN D RECEPTOR;

CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; IMMUNOPATHOGENESIS; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; VITAMIN BLOOD LEVEL;

EID: 33845706266     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1375.050     Document Type: Conference Paper

References (16)

1. MATHIEU, C., J. LAUREYS, H. SOBIS, et al. 1992. 1,25-Dihydroxyvitamin D3 prevents insulitis in NOD mice. Diabetes 41: 1491-1495.
2. GIULIETTI, A., C. GYSEMANS, K. STOFFELS, et al. 2004. Vitamin D deficiency in early life accelerates Type 1 diabetes in non-obese diabetic mice. Diabetologia 47: 451-462.
3. MATTNER, F., S. SMIROLDO, F. GALBIATI, et al. 2000. Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D(3). Eur. J. Immunol. 30: 498-508.
4. D'AMBROSIO, D., M. CIPPITELLI, M.G. COCCIOLO, et al. 1998. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB down-regulation in transcriptional repression of the p40 gene. J. Clin. Invest. 101: 252-262.
5. VELDMAN, C.M., M.T. CANTORNA & H.F. DELUCA. 2000. Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. Arch. Biochem. Biophys. 374: 334-338.
6. MIYAMOTO, K., R.A. KESTERSON, H. YAMAMOTO, et al. 1997. Structural organization of the human vitamin D receptor chromosomal gene and its promoter. Mol. Endocrinol. 11: 1165-1179.
7. KOSZEWSKI, N.J., S. KIESSLING & H.H. MALLUCHE. 2001. Isolation of genomic DNA sequences that bind vitamin D receptor complexes. Biochem. Biophys. Res. Commun. 283: 188-194.
8. ANGEL, B., J.L. SANTOS, E. CARRASCO, et al. 2004. Vitamin D receptor polymorphism and susceptibility to type 1 diabetes in Chilean subjects: a case-parent study Eur. Eur. J. Epidemiol. 19: 1085-1087.
9. PANI, M.A., M. KNAPP, H. DONNER, et al. 2000. Vitamin D receptor allele combinations influence genetic susceptibility to type 1 diabetes in Germans. Diabetes 49: 504-507.
10. TURPEINEN, H., R. HERMANN, S. VAARA, et al. 2003. Vitamin D receptor polymorphisms: no association with type 1 diabetes in the Finnish population. Eur. J. Endocrinol. 149: 591-596.
11. NEJENTSEV, S., J.D. COOPER, L. GODFREY, et al. 2004. Analysis of the vitamin D receptor gene sequence variants in type 1 diabetes. Diabetes 53: 2709-2712.
12. MALABANAN, A., I.E. VERONIKIS & M.F. HOLICK. 1998. Redefining vitamin D insufficiency. Lancet 351: 805-806.
13. OGUNKOLADE, B.W., B.J. BOUCHER, P.D. FAIRCLOUGH, et al. 2002. Expression of 25-hydroxyvitamin D-1-alpha-hydroxylase mRNA in individuals with colorectal cancer. Lancet 359: 1831-1832.
14. DUDBRIDGE, F. 2003. Pedigree disequilibrium tests for multilocus haplotypes. Genet. Epidemiol. 25: 115-121.
15. BAN, Y., M. TANIYAMA & Y. BAN. 2000. Vitamin D receptor gene polymorphism is associated with Graves' disease in the Japanese population. J. Clin. Endocrinol. Metab. 85: 4639-4643.
16. OGUNKOLADE, B.W., B.J. BOUCHER, J.M. PRAHL, et al. 2002. Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians. Diabetes 51: 2294-2300.